Advertisements

Tatton Asset Management Grants New Stock Options to Executives

by Daisy

Tatton Asset Management PLC (AIM: TAM), a company specializing in investment management and financial advisory services, has announced the issuance of new stock options to its senior leadership under the Enterprise Management Incentive (EMI) scheme. The options, which come at no cost to the executives, will allow them to purchase ordinary shares if they achieve specific performance goals by March 31, 2027.

The options have been awarded to three prominent executives: CEO Paul Hogarth, CFO Paul Edwards, and CIO Lothar Mentel. Hogarth has been granted the option to acquire up to 110,887 shares, bringing his total unexercised options to 481,743. Edwards has been awarded options for 70,565 shares, bringing his total to 283,223, while Mentel receives the same number of options, increasing his total to 1,349,338.

Advertisements

In total, 252,017 new options have been granted, raising the total number of unexercised options for the company to 2,114,304, excluding those in the employee sharesave scheme. Additionally, 1,712,287 options have vested but remain unexercised.

Advertisements

The vesting of these options is contingent on the fulfillment of performance targets outlined in the company’s Annual Remuneration Committee Report. The Remuneration Committee has expressed confidence that the criteria are reasonable and will incentivize the executives to focus on long-term growth.

This move is part of Tatton Asset Management’s broader strategy to align the leadership team’s interests with those of shareholders and ensure the company’s sustained success.

You May Also Like

blank

Futuresstocktrading.com is a comprehensive futures information portal. Whether you’re a novice or seasoned trader, find futures news, futures market, futures trading tips, and futures basic knowledge to enhance your trading prowess and financial success.

[Contact us: [email protected]]

© 2023 Copyright  Futuresstocktrading.com – Futures Market, Investment, Trading & News